- Page 1/3
- Next Page
COMMENT
Market Outlook He sees extreme oversold indicators in the market right now. The market has discounted a deep recession for next year, which is good, he thinks. Now the market looks forward and there is great opportunity. Looking at corporate earnings and GDP growth he is not too pessimistic; rather thinking that a lot of the issues concerning the market are transient. You need to take on a non-emotional view of the market. His balanced portfolio is about 6% above his benchmark -- he is pleased with his performance this year.
COMMENT
CVS or BAC? He owns both and struggles to pick one over the other. Building a portfolio with different balances makes sense. CVS is a little out of favour as it is being "Amazoned". However, they have 11,000 locations in the US and have set up mini-health clinics with nurses on staff -- a good differentiation. BAC has corrected and is now trading at recessionary levels (below book value) -- extreme levels not seen since 2008 and great value.
specialty stores
COMMENT
CVS or BAC? He owns both and struggles to pick one over the other. Building a portfolio with different balances makes sense. CVS is a little out of favour as it is being "Amazoned". However, they have 11,000 locations in the US and have set up mini-health clinics with nurses on staff -- a good differentiation. BAC has corrected and is now trading at recessionary levels (below book value) -- extreme levels not seen since 2008 and great value.
banks
DON'T BUY
They make their money by constantly cost cutting. When their drugs go off-patent then they need to find another to replace it. It is a leaky-boat story. When you look at the cost multiples, which he thinks are expensive, he would pass on this. He would consider bio-pharma instead.
biotechnology
pharmaceutical
BUY
They have 13,000 stores in the US and just bought many more stores recently. They struggled to bring those into the structure, but feels they are going to do well. Trading at 12.5 times earnings (about 30% discount to normal). It is a Dow component. He thinks there are good things to come.
specialty stores
PAST TOP PICK
(A Top Pick Jan 30/18, Up 2%) It got mired in owning ABC and ESPN, which struggled with lost subscribers. They then made an offer for 21st Century Fox -- this was a great buy. He felt this diluted the impact of owning ABC and ESPN. They can move the Disney library online and compete against Netflix. They are trading at 15 times earnings and it has a long runaway ahead of itself.
entertainment services
PAST TOP PICK
(A Top Pick Jan 30/18, Down 13%) This company makes carbon-fibre materials with 66% of their revenue in the commercial airline businesses -- such as Boeing. They make the skin on aircraft. The lightweight material adds to fuel efficiencies. They trade at 20 times earnings. He thinks it is being impacted by issues with China, but he thinks this will pass.
0
PAST TOP PICK
(A Top Pick Jan 30/18, Up 5%) This stock was bought by AT&T back in June 2018. The US Justice Department originally challenged the takeover, which had given him another opportunity to buy and profit along the way. He would not be interested in owning AT&T as he does not like the direction they are going -- buying DirectTV (which is highly capital intensive).
Broadcasting
BUY ON WEAKNESS
Class action lawsuit? He was not aware of any class action lawsuit. He likes the membership revenues as it creates a competitive advantage over Walmart and others. The valuation is always a little to rich for him. He is not sure that expansion to Europe will be wildly successful. He is ambivalent, but would look to buy on weakness -- at better valuation metrics.
department stores
